{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "32dfac7f",
   "metadata": {},
   "source": [
    "# Correlates of Protection (CoP) Statistical Analysis Plan\n",
    "\n",
    "**Author:** Statistical Analysis Team  \n",
    "**Date:** July 2025  \n",
    "**Version:** 1.0\n",
    "\n",
    "---\n",
    "\n",
    "## Table of Contents\n",
    "1. [Library Imports](#1-library-imports)\n",
    "2. [Study Overview and Objectives](#2-study-overview-and-objectives)\n",
    "3. [Study Design and Endpoints](#3-study-design-and-endpoints)\n",
    "4. [Statistical Methods](#4-statistical-methods)\n",
    "5. [Data Simulation](#5-data-simulation)\n",
    "6. [Statistical Analysis in R](#6-statistical-analysis-in-r)\n",
    "7. [Results Interpretation](#7-results-interpretation)\n",
    "8. [Best Practices and Recommendations](#8-best-practices-and-recommendations)\n",
    "\n",
    "---"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4cdb874a",
   "metadata": {},
   "source": [
    "## 1. Library Imports\n",
    "\n",
    "We'll load the necessary R packages for our correlates of protection analysis."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8205baf7",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load required libraries\n",
    "library(tidyverse)    # Data manipulation and visualization\n",
    "library(survival)     # Survival analysis\n",
    "library(survminer)    # Survival plot enhancements\n",
    "library(pROC)         # ROC curve analysis\n",
    "library(gridExtra)    # Multiple plot arrangements\n",
    "library(corrplot)     # Correlation plots\n",
    "library(ggplot2)      # Advanced plotting\n",
    "library(dplyr)        # Data manipulation\n",
    "library(broom)        # Model summaries\n",
    "library(knitr)        # Table formatting\n",
    "library(kableExtra)   # Enhanced table formatting\n",
    "library(boot)         # Bootstrap methods\n",
    "library(MASS)         # Statistical functions\n",
    "library(car)          # Regression diagnostics\n",
    "\n",
    "# Set random seed for reproducibility\n",
    "set.seed(42)\n",
    "\n",
    "# Print session info\n",
    "cat(\"R Session Info:\\n\")\n",
    "print(sessionInfo())"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c61975dd",
   "metadata": {},
   "source": [
    "## 2. Study Overview and Objectives\n",
    "\n",
    "### 2.1 Background\n",
    "\n",
    "Correlates of Protection (CoP) studies are essential in vaccine development and infectious disease research. These studies aim to identify immunological markers that predict protection against infection or disease. Understanding CoP helps in:\n",
    "\n",
    "- **Vaccine development**: Identifying biomarkers that predict vaccine efficacy\n",
    "- **Regulatory approval**: Providing evidence for vaccine licensing\n",
    "- **Public health decisions**: Informing vaccination strategies\n",
    "- **Clinical trial design**: Optimizing future studies\n",
    "\n",
    "### 2.2 Study Objectives\n",
    "\n",
    "#### Primary Objective\n",
    "To identify immunological correlates of protection against [specific pathogen/disease] and establish threshold levels associated with protection.\n",
    "\n",
    "#### Secondary Objectives\n",
    "1. Evaluate the relationship between antibody levels and protection\n",
    "2. Assess the durability of immune responses\n",
    "3. Identify factors that influence immune response variability\n",
    "4. Develop predictive models for protection\n",
    "\n",
    "### 2.3 Study Population\n",
    "\n",
    "- **Target Population**: Healthy adults aged 18-65 years\n",
    "- **Sample Size**: 500 participants\n",
    "- **Follow-up Period**: 12 months\n",
    "- **Study Design**: Prospective cohort study"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "abff7ee4",
   "metadata": {},
   "source": [
    "## 3. Study Design and Endpoints\n",
    "\n",
    "### 3.1 Study Design\n",
    "\n",
    "This is a prospective cohort study designed to identify correlates of protection. Participants will be followed for 12 months after vaccination to assess:\n",
    "\n",
    "1. **Immunological markers** (antibody levels, T-cell responses)\n",
    "2. **Clinical outcomes** (infection, disease severity)\n",
    "3. **Demographic and clinical covariates**\n",
    "\n",
    "### 3.2 Primary Endpoint\n",
    "\n",
    "**Laboratory-confirmed infection** within 12 months of vaccination\n",
    "- Binary outcome: Yes/No\n",
    "- Confirmed by RT-PCR or antigen testing\n",
    "\n",
    "### 3.3 Secondary Endpoints\n",
    "\n",
    "1. **Time to infection** (survival analysis)\n",
    "2. **Disease severity** (ordinal scale: asymptomatic, mild, moderate, severe)\n",
    "3. **Antibody persistence** (continuous measures over time)\n",
    "4. **Breakthrough infection rate** by antibody quartiles\n",
    "\n",
    "### 3.4 Immunological Assessments\n",
    "\n",
    "1. **Neutralizing antibodies** (primary biomarker)\n",
    "2. **Binding antibodies** (IgG, IgA, IgM)\n",
    "3. **T-cell responses** (CD4+, CD8+)\n",
    "4. **Cytokine profiles**\n",
    "\n",
    "### 3.5 Timeline\n",
    "\n",
    "- **Baseline** (Day 0): Pre-vaccination\n",
    "- **Day 28**: Post-vaccination (peak response)\n",
    "- **Month 3, 6, 9, 12**: Follow-up visits\n",
    "- **Unscheduled visits**: Symptomatic illness"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6a9503c2",
   "metadata": {},
   "source": [
    "## 4. Statistical Methods\n",
    "\n",
    "### 4.1 General Principles\n",
    "\n",
    "- **Significance Level**: α = 0.05 (two-sided)\n",
    "- **Missing Data**: Multiple imputation for missing immunological data\n",
    "- **Multiple Testing**: Benjamini-Hochberg correction for multiple comparisons\n",
    "- **Analysis Populations**: \n",
    "  - Intent-to-treat (ITT)\n",
    "  - Per-protocol (PP)\n",
    "  - Immunogenicity evaluable population\n",
    "\n",
    "### 4.2 Correlates of Protection Analysis\n",
    "\n",
    "#### 4.2.1 Logistic Regression\n",
    "Primary method for identifying correlates of protection:\n",
    "\n",
    "$$\\text{logit}(P(\\text{protection})) = \\beta_0 + \\beta_1 \\log(\\text{antibody}) + \\beta_2 \\text{age} + \\beta_3 \\text{sex} + \\ldots$$\n",
    "\n",
    "#### 4.2.2 Survival Analysis\n",
    "Cox proportional hazards model for time-to-infection:\n",
    "\n",
    "$$h(t|X) = h_0(t) \\exp(\\beta_1 \\log(\\text{antibody}) + \\beta_2 X_2 + \\ldots)$$\n",
    "\n",
    "#### 4.2.3 ROC Analysis\n",
    "Receiver Operating Characteristic curves to:\n",
    "- Assess discriminatory ability\n",
    "- Determine optimal threshold levels\n",
    "- Calculate sensitivity and specificity\n",
    "\n",
    "#### 4.2.4 Threshold Analysis\n",
    "Methods to establish protection thresholds:\n",
    "- **Quantile regression**: 50%, 80%, 90% protection levels\n",
    "- **Prentice criteria**: Statistical framework for CoP validation\n",
    "- **Bootstrap confidence intervals**: Uncertainty quantification\n",
    "\n",
    "### 4.3 Sample Size Calculation\n",
    "\n",
    "For logistic regression with 80% power, α = 0.05:\n",
    "- **Expected attack rate**: 20%\n",
    "- **Detectable OR**: 0.5 per log10 increase in antibody\n",
    "- **Required sample size**: 500 participants\n",
    "\n",
    "### 4.4 Statistical Software\n",
    "\n",
    "Primary analysis will be conducted in R using:\n",
    "- Base R statistical functions\n",
    "- Specialized packages for survival analysis, ROC curves\n",
    "- Custom functions for CoP-specific analyses"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9a75ddd5",
   "metadata": {},
   "source": [
    "## 5. Data Simulation\n",
    "\n",
    "To demonstrate the statistical methods, we'll simulate a realistic dataset that represents a correlates of protection study."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a3994f91",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Simulate correlates of protection data\n",
    "simulate_cop_data <- function(n = 500, seed = 42) {\n",
    "  set.seed(seed)\n",
    "  \n",
    "  # Baseline characteristics\n",
    "  age <- round(rnorm(n, mean = 45, sd = 15))\n",
    "  age[age < 18] <- 18\n",
    "  age[age > 65] <- 65\n",
    "  \n",
    "  sex <- sample(c(\"Male\", \"Female\"), n, replace = TRUE, prob = c(0.48, 0.52))\n",
    "  \n",
    "  # Comorbidities\n",
    "  diabetes <- rbinom(n, 1, 0.12)\n",
    "  hypertension <- rbinom(n, 1, 0.25)\n",
    "  bmi <- round(rnorm(n, mean = 26, sd = 4), 1)\n",
    "  \n",
    "  # Vaccination history\n",
    "  prior_vaccination <- rbinom(n, 1, 0.15)\n",
    "  \n",
    "  # Immunological responses (post-vaccination)\n",
    "  # Log-normal distribution for antibody levels\n",
    "  log_antibody_mean <- 2.5 + 0.02 * (age - 45) + 0.3 * (sex == \"Female\") - 0.2 * diabetes\n",
    "  log_antibody <- rnorm(n, mean = log_antibody_mean, sd = 0.8)\n",
    "  antibody_level <- exp(log_antibody)\n",
    "  \n",
    "  # T-cell responses (correlated with antibody)\n",
    "  t_cell_response <- exp(0.5 * log_antibody + rnorm(n, 0, 0.3))\n",
    "  \n",
    "  # Infection outcome (based on antibody levels and other factors)\n",
    "  # Higher antibody levels = lower infection risk\n",
    "  logit_infection <- -1.5 - 0.8 * log_antibody + 0.01 * age + 0.3 * diabetes + 0.2 * hypertension\n",
    "  infection_prob <- 1 / (1 + exp(-logit_infection))\n",
    "  infected <- rbinom(n, 1, infection_prob)\n",
    "  \n",
    "  # Time to infection (for survival analysis)\n",
    "  # Those who don't get infected are censored at 365 days\n",
    "  lambda <- exp(-2 - 0.5 * log_antibody)  # Hazard rate\n",
    "  time_to_infection <- rexp(n, lambda)\n",
    "  time_to_infection[infected == 0] <- NA\n",
    "  \n",
    "  # Create follow-up time (censoring time)\n",
    "  follow_up_time <- ifelse(infected == 1 & !is.na(time_to_infection), \n",
    "                          pmin(time_to_infection, 365), 365)\n",
    "  \n",
    "  # Disease severity (among infected)\n",
    "  # Lower antibody levels = higher severity\n",
    "  severity_prob <- ifelse(infected == 1, \n",
    "                         pmax(0.1, 0.7 - 0.2 * log_antibody), 0)\n",
    "  severity <- ifelse(infected == 1, \n",
    "                    sample(c(\"Asymptomatic\", \"Mild\", \"Moderate\", \"Severe\"), \n",
    "                           n, replace = TRUE, \n",
    "                           prob = c(0.3, 0.5, 0.15, 0.05)), NA)\n",
    "  \n",
    "  # Create the dataset\n",
    "  data <- data.frame(\n",
    "    subject_id = 1:n,\n",
    "    age = age,\n",
    "    sex = sex,\n",
    "    bmi = bmi,\n",
    "    diabetes = diabetes,\n",
    "    hypertension = hypertension,\n",
    "    prior_vaccination = prior_vaccination,\n",
    "    antibody_level = round(antibody_level, 2),\n",
    "    log_antibody = round(log_antibody, 3),\n",
    "    t_cell_response = round(t_cell_response, 2),\n",
    "    infected = infected,\n",
    "    follow_up_time = round(follow_up_time, 0),\n",
    "    time_to_infection = round(time_to_infection, 0),\n",
    "    severity = severity,\n",
    "    stringsAsFactors = FALSE\n",
    "  )\n",
    "  \n",
    "  return(data)\n",
    "}\n",
    "\n",
    "# Generate the dataset\n",
    "cop_data <- simulate_cop_data(n = 500)\n",
    "\n",
    "# Display first few rows\n",
    "head(cop_data, 10) %>%\n",
    "  kable(caption = \"First 10 rows of simulated CoP dataset\") %>%\n",
    "  kable_styling(bootstrap_options = c(\"striped\", \"hover\"))\n",
    "\n",
    "# Summary statistics\n",
    "cat(\"\\n=== DATASET SUMMARY ===\\n\")\n",
    "cat(\"Total participants:\", nrow(cop_data), \"\\n\")\n",
    "cat(\"Number infected:\", sum(cop_data$infected), \"\\n\")\n",
    "cat(\"Attack rate:\", round(mean(cop_data$infected) * 100, 1), \"%\\n\")\n",
    "cat(\"Mean antibody level:\", round(mean(cop_data$antibody_level), 2), \"\\n\")\n",
    "cat(\"Median follow-up time:\", median(cop_data$follow_up_time), \"days\\n\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "492f636b",
   "metadata": {},
   "source": [
    "### 5.1 Data Exploration and Visualization"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "78ee6fa0",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Descriptive statistics by infection status\n",
    "descriptive_stats <- cop_data %>%\n",
    "  group_by(infected) %>%\n",
    "  summarise(\n",
    "    n = n(),\n",
    "    mean_age = round(mean(age), 1),\n",
    "    mean_antibody = round(mean(antibody_level), 2),\n",
    "    median_antibody = round(median(antibody_level), 2),\n",
    "    sd_antibody = round(sd(antibody_level), 2),\n",
    "    pct_female = round(mean(sex == \"Female\") * 100, 1),\n",
    "    pct_diabetes = round(mean(diabetes) * 100, 1)\n",
    "  )\n",
    "\n",
    "descriptive_stats %>%\n",
    "  kable(caption = \"Descriptive Statistics by Infection Status\") %>%\n",
    "  kable_styling(bootstrap_options = c(\"striped\", \"hover\"))\n",
    "\n",
    "# Visualization: Antibody levels by infection status\n",
    "p1 <- ggplot(cop_data, aes(x = factor(infected), y = antibody_level, fill = factor(infected))) +\n",
    "  geom_boxplot(alpha = 0.7) +\n",
    "  geom_jitter(width = 0.2, alpha = 0.5) +\n",
    "  scale_y_log10() +\n",
    "  labs(title = \"Antibody Levels by Infection Status\",\n",
    "       x = \"Infected (0 = No, 1 = Yes)\",\n",
    "       y = \"Antibody Level (log scale)\",\n",
    "       fill = \"Infected\") +\n",
    "  theme_minimal() +\n",
    "  theme(legend.position = \"none\")\n",
    "\n",
    "# Correlation matrix\n",
    "cor_vars <- cop_data %>%\n",
    "  select(age, antibody_level, t_cell_response, infected) %>%\n",
    "  cor(use = \"complete.obs\")\n",
    "\n",
    "# Create correlation plot\n",
    "p2 <- corrplot(cor_vars, method = \"color\", type = \"upper\", \n",
    "               order = \"hclust\", tl.cex = 0.8, tl.col = \"black\")\n",
    "\n",
    "# Display plots\n",
    "print(p1)\n",
    "\n",
    "# Antibody distribution\n",
    "p3 <- ggplot(cop_data, aes(x = antibody_level)) +\n",
    "  geom_histogram(bins = 30, alpha = 0.7, fill = \"steelblue\") +\n",
    "  scale_x_log10() +\n",
    "  labs(title = \"Distribution of Antibody Levels\",\n",
    "       x = \"Antibody Level (log scale)\",\n",
    "       y = \"Frequency\") +\n",
    "  theme_minimal()\n",
    "\n",
    "print(p3)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "84bb00b1",
   "metadata": {},
   "source": [
    "## 6. Statistical Analysis in R\n",
    "\n",
    "### 6.1 Primary Analysis: Logistic Regression for Correlates of Protection"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "43fe7b20",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Primary logistic regression model\n",
    "# Outcome: infection (0 = protected, 1 = infected)\n",
    "# We model infection risk, so lower antibody = higher risk\n",
    "\n",
    "# Univariate analysis\n",
    "model_univariate <- glm(infected ~ log_antibody, \n",
    "                       data = cop_data, \n",
    "                       family = binomial)\n",
    "\n",
    "# Multivariate analysis\n",
    "model_multivariate <- glm(infected ~ log_antibody + age + sex + diabetes + hypertension,\n",
    "                         data = cop_data,\n",
    "                         family = binomial)\n",
    "\n",
    "# Model summaries\n",
    "cat(\"=== UNIVARIATE LOGISTIC REGRESSION ===\\n\")\n",
    "summary(model_univariate)\n",
    "\n",
    "cat(\"\\n=== MULTIVARIATE LOGISTIC REGRESSION ===\\n\")\n",
    "summary(model_multivariate)\n",
    "\n",
    "# Extract odds ratios and confidence intervals\n",
    "univariate_or <- exp(cbind(coef(model_univariate), confint(model_univariate)))\n",
    "multivariate_or <- exp(cbind(coef(model_multivariate), confint(model_multivariate)))\n",
    "\n",
    "cat(\"\\n=== ODDS RATIOS (95% CI) ===\\n\")\n",
    "cat(\"Univariate - Log Antibody:\\n\")\n",
    "print(round(univariate_or, 3))\n",
    "\n",
    "cat(\"\\nMultivariate Model:\\n\")\n",
    "print(round(multivariate_or, 3))\n",
    "\n",
    "# Calculate vaccine efficacy by antibody quartiles\n",
    "cop_data$antibody_quartile <- cut(cop_data$antibody_level, \n",
    "                                 breaks = quantile(cop_data$antibody_level, \n",
    "                                                  c(0, 0.25, 0.5, 0.75, 1)), \n",
    "                                 labels = c(\"Q1\", \"Q2\", \"Q3\", \"Q4\"),\n",
    "                                 include.lowest = TRUE)\n",
    "\n",
    "infection_by_quartile <- cop_data %>%\n",
    "  group_by(antibody_quartile) %>%\n",
    "  summarise(\n",
    "    n = n(),\n",
    "    infections = sum(infected),\n",
    "    attack_rate = round(mean(infected) * 100, 1),\n",
    "    .groups = 'drop'\n",
    "  )\n",
    "\n",
    "infection_by_quartile %>%\n",
    "  kable(caption = \"Infection Rate by Antibody Quartile\") %>%\n",
    "  kable_styling(bootstrap_options = c(\"striped\", \"hover\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4b09d8f9",
   "metadata": {},
   "source": [
    "### 6.2 ROC Analysis and Threshold Determination"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d31f3565",
   "metadata": {},
   "outputs": [],
   "source": [
    "# ROC analysis for antibody levels\n",
    "# Note: we use 1-infected as outcome since we want to predict protection\n",
    "roc_analysis <- roc(response = 1 - cop_data$infected, \n",
    "                   predictor = cop_data$antibody_level)\n",
    "\n",
    "# Calculate AUC and confidence interval\n",
    "auc_value <- auc(roc_analysis)\n",
    "auc_ci <- ci.auc(roc_analysis)\n",
    "\n",
    "cat(\"=== ROC ANALYSIS RESULTS ===\\n\")\n",
    "cat(\"AUC:\", round(auc_value, 3), \"\\n\")\n",
    "cat(\"95% CI:\", round(auc_ci[1], 3), \"-\", round(auc_ci[3], 3), \"\\n\")\n",
    "\n",
    "# Find optimal threshold using Youden's J statistic\n",
    "optimal_threshold <- coords(roc_analysis, \"best\", ret = \"threshold\")\n",
    "optimal_coords <- coords(roc_analysis, \"best\", ret = c(\"threshold\", \"sensitivity\", \"specificity\"))\n",
    "\n",
    "cat(\"\\n=== OPTIMAL THRESHOLD ===\\n\")\n",
    "cat(\"Threshold:\", round(optimal_threshold, 2), \"\\n\")\n",
    "cat(\"Sensitivity:\", round(optimal_coords$sensitivity, 3), \"\\n\")\n",
    "cat(\"Specificity:\", round(optimal_coords$specificity, 3), \"\\n\")\n",
    "\n",
    "# Plot ROC curve\n",
    "roc_plot <- ggroc(roc_analysis) +\n",
    "  geom_abline(intercept = 1, slope = 1, linetype = \"dashed\", color = \"red\") +\n",
    "  labs(title = paste0(\"ROC Curve for Antibody Levels\\nAUC = \", round(auc_value, 3)),\n",
    "       x = \"Specificity\",\n",
    "       y = \"Sensitivity\") +\n",
    "  theme_minimal()\n",
    "\n",
    "print(roc_plot)\n",
    "\n",
    "# Calculate protection levels at different thresholds\n",
    "thresholds <- c(10, 20, 50, 100, 200, 500)\n",
    "protection_analysis <- data.frame(\n",
    "  threshold = thresholds,\n",
    "  n_above = sapply(thresholds, function(x) sum(cop_data$antibody_level >= x)),\n",
    "  pct_above = sapply(thresholds, function(x) round(mean(cop_data$antibody_level >= x) * 100, 1)),\n",
    "  attack_rate_above = sapply(thresholds, function(x) {\n",
    "    subset_data <- cop_data[cop_data$antibody_level >= x, ]\n",
    "    if(nrow(subset_data) > 0) {\n",
    "      round(mean(subset_data$infected) * 100, 1)\n",
    "    } else {\n",
    "      NA\n",
    "    }\n",
    "  }),\n",
    "  attack_rate_below = sapply(thresholds, function(x) {\n",
    "    subset_data <- cop_data[cop_data$antibody_level < x, ]\n",
    "    if(nrow(subset_data) > 0) {\n",
    "      round(mean(subset_data$infected) * 100, 1)\n",
    "    } else {\n",
    "      NA\n",
    "    }\n",
    "  })\n",
    ")\n",
    "\n",
    "protection_analysis %>%\n",
    "  kable(caption = \"Protection Analysis by Antibody Threshold\") %>%\n",
    "  kable_styling(bootstrap_options = c(\"striped\", \"hover\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4089f441",
   "metadata": {},
   "source": [
    "### 6.3 Survival Analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e0b8d8b5",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Prepare survival data\n",
    "# Create event indicator (1 = infected, 0 = censored)\n",
    "cop_data$event <- cop_data$infected\n",
    "cop_data$time <- cop_data$follow_up_time\n",
    "\n",
    "# Create survival object\n",
    "surv_object <- Surv(time = cop_data$time, event = cop_data$event)\n",
    "\n",
    "# Kaplan-Meier survival curves by antibody quartiles\n",
    "km_fit <- survfit(surv_object ~ antibody_quartile, data = cop_data)\n",
    "\n",
    "# Plot survival curves\n",
    "km_plot <- ggsurvplot(\n",
    "  km_fit,\n",
    "  data = cop_data,\n",
    "  pval = TRUE,\n",
    "  conf.int = TRUE,\n",
    "  risk.table = TRUE,\n",
    "  risk.table.col = \"strata\",\n",
    "  linetype = \"strata\",\n",
    "  surv.median.line = \"hv\",\n",
    "  ggtheme = theme_minimal(),\n",
    "  palette = c(\"#E7B800\", \"#2E9FDF\", \"#00AFBB\", \"#FC4E07\"),\n",
    "  title = \"Survival Curves by Antibody Quartile\",\n",
    "  xlab = \"Time (days)\",\n",
    "  ylab = \"Survival Probability (Infection-free)\"\n",
    ")\n",
    "\n",
    "print(km_plot)\n",
    "\n",
    "# Cox proportional hazards model\n",
    "cox_model <- coxph(surv_object ~ log_antibody + age + sex + diabetes + hypertension,\n",
    "                   data = cop_data)\n",
    "\n",
    "cat(\"\\n=== COX PROPORTIONAL HAZARDS MODEL ===\\n\")\n",
    "summary(cox_model)\n",
    "\n",
    "# Test proportional hazards assumption\n",
    "cox_zph <- cox.zph(cox_model)\n",
    "cat(\"\\n=== PROPORTIONAL HAZARDS TEST ===\\n\")\n",
    "print(cox_zph)\n",
    "\n",
    "# Calculate hazard ratios\n",
    "cox_hr <- exp(cbind(coef(cox_model), confint(cox_model)))\n",
    "cat(\"\\n=== HAZARD RATIOS (95% CI) ===\\n\")\n",
    "print(round(cox_hr, 3))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5925577d",
   "metadata": {},
   "source": [
    "### 6.4 Dose-Response Analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ced6719a",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Dose-response curve\n",
    "# Create prediction data\n",
    "antibody_range <- seq(min(cop_data$antibody_level), max(cop_data$antibody_level), length.out = 100)\n",
    "pred_data <- data.frame(\n",
    "  log_antibody = log(antibody_range),\n",
    "  age = mean(cop_data$age),\n",
    "  sex = \"Female\",\n",
    "  diabetes = 0,\n",
    "  hypertension = 0\n",
    ")\n",
    "\n",
    "# Predict infection probability\n",
    "pred_prob <- predict(model_multivariate, newdata = pred_data, type = \"response\")\n",
    "pred_protection <- 1 - pred_prob\n",
    "\n",
    "# Create dose-response plot\n",
    "dose_response_data <- data.frame(\n",
    "  antibody_level = antibody_range,\n",
    "  protection_prob = pred_protection\n",
    ")\n",
    "\n",
    "dose_response_plot <- ggplot(dose_response_data, aes(x = antibody_level, y = protection_prob)) +\n",
    "  geom_line(size = 1.2, color = \"blue\") +\n",
    "  geom_hline(yintercept = c(0.5, 0.8, 0.9), linetype = \"dashed\", alpha = 0.6) +\n",
    "  scale_x_log10() +\n",
    "  labs(\n",
    "    title = \"Dose-Response Curve: Antibody Level vs Protection Probability\",\n",
    "    x = \"Antibody Level (log scale)\",\n",
    "    y = \"Protection Probability\",\n",
    "    caption = \"Dashed lines at 50%, 80%, and 90% protection levels\"\n",
    "  ) +\n",
    "  theme_minimal()\n",
    "\n",
    "print(dose_response_plot)\n",
    "\n",
    "# Calculate antibody levels for specific protection levels\n",
    "protection_levels <- c(0.5, 0.8, 0.9)\n",
    "antibody_thresholds <- sapply(protection_levels, function(target) {\n",
    "  idx <- which.min(abs(pred_protection - target))\n",
    "  antibody_range[idx]\n",
    "})\n",
    "\n",
    "threshold_table <- data.frame(\n",
    "  protection_level = paste0(protection_levels * 100, \"%\"),\n",
    "  antibody_threshold = round(antibody_thresholds, 2)\n",
    ")\n",
    "\n",
    "threshold_table %>%\n",
    "  kable(caption = \"Antibody Thresholds for Different Protection Levels\") %>%\n",
    "  kable_styling(bootstrap_options = c(\"striped\", \"hover\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3d7f88b7",
   "metadata": {},
   "source": [
    "### 6.5 Bootstrap Analysis for Confidence Intervals"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "21f34559",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Bootstrap analysis for threshold confidence intervals\n",
    "bootstrap_threshold <- function(data, indices, protection_level = 0.8) {\n",
    "  # Sample with replacement\n",
    "  boot_data <- data[indices, ]\n",
    "  \n",
    "  # Fit model\n",
    "  tryCatch({\n",
    "    model <- glm(infected ~ log_antibody + age + sex + diabetes + hypertension,\n",
    "                data = boot_data, family = binomial)\n",
    "    \n",
    "    # Create prediction data\n",
    "    antibody_range <- seq(min(boot_data$antibody_level), \n",
    "                         max(boot_data$antibody_level), length.out = 100)\n",
    "    pred_data <- data.frame(\n",
    "      log_antibody = log(antibody_range),\n",
    "      age = mean(boot_data$age),\n",
    "      sex = \"Female\",\n",
    "      diabetes = 0,\n",
    "      hypertension = 0\n",
    "    )\n",
    "    \n",
    "    # Predict protection probability\n",
    "    pred_prob <- predict(model, newdata = pred_data, type = \"response\")\n",
    "    pred_protection <- 1 - pred_prob\n",
    "    \n",
    "    # Find threshold\n",
    "    idx <- which.min(abs(pred_protection - protection_level))\n",
    "    return(antibody_range[idx])\n",
    "  }, error = function(e) {\n",
    "    return(NA)\n",
    "  })\n",
    "}\n",
    "\n",
    "# Perform bootstrap (reduced number for demonstration)\n",
    "cat(\"Performing bootstrap analysis (this may take a moment)...\\n\")\n",
    "boot_results <- boot(data = cop_data, \n",
    "                    statistic = bootstrap_threshold, \n",
    "                    R = 100,  # Reduced for demonstration\n",
    "                    protection_level = 0.8)\n",
    "\n",
    "# Calculate confidence intervals\n",
    "boot_ci <- boot.ci(boot_results, type = \"perc\")\n",
    "\n",
    "cat(\"\\n=== BOOTSTRAP RESULTS FOR 80% PROTECTION THRESHOLD ===\\n\")\n",
    "cat(\"Original estimate:\", round(boot_results$t0, 2), \"\\n\")\n",
    "cat(\"Bootstrap mean:\", round(mean(boot_results$t, na.rm = TRUE), 2), \"\\n\")\n",
    "cat(\"95% CI:\", round(boot_ci$percent[4], 2), \"-\", round(boot_ci$percent[5], 2), \"\\n\")\n",
    "\n",
    "# Plot bootstrap distribution\n",
    "boot_plot <- ggplot(data.frame(threshold = boot_results$t), aes(x = threshold)) +\n",
    "  geom_histogram(bins = 20, alpha = 0.7, fill = \"steelblue\") +\n",
    "  geom_vline(xintercept = boot_results$t0, color = \"red\", linetype = \"dashed\") +\n",
    "  labs(\n",
    "    title = \"Bootstrap Distribution of 80% Protection Threshold\",\n",
    "    x = \"Antibody Threshold\",\n",
    "    y = \"Frequency\",\n",
    "    caption = \"Red line: original estimate\"\n",
    "  ) +\n",
    "  theme_minimal()\n",
    "\n",
    "print(boot_plot)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "eef70938",
   "metadata": {},
   "source": [
    "## 7. Results Interpretation\n",
    "\n",
    "### 7.1 Key Findings Summary"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "94ef38af",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Create comprehensive results summary\n",
    "cat(\"\\n\", \"=\"*60, \"\\n\")\n",
    "cat(\"                 CORRELATES OF PROTECTION ANALYSIS\\n\")\n",
    "cat(\"                        RESULTS SUMMARY\\n\")\n",
    "cat(\"=\"*60, \"\\n\")\n",
    "\n",
    "# Study population summary\n",
    "cat(\"\\n1. STUDY POPULATION:\\n\")\n",
    "cat(\"   - Total participants:\", nrow(cop_data), \"\\n\")\n",
    "cat(\"   - Infections observed:\", sum(cop_data$infected), \"\\n\")\n",
    "cat(\"   - Overall attack rate:\", round(mean(cop_data$infected) * 100, 1), \"%\\n\")\n",
    "cat(\"   - Mean age:\", round(mean(cop_data$age), 1), \"years\\n\")\n",
    "cat(\"   - Female proportion:\", round(mean(cop_data$sex == \"Female\") * 100, 1), \"%\\n\")\n",
    "\n",
    "# Antibody analysis\n",
    "cat(\"\\n2. ANTIBODY ANALYSIS:\\n\")\n",
    "cat(\"   - Median antibody level (infected):\", \n",
    "    round(median(cop_data$antibody_level[cop_data$infected == 1]), 2), \"\\n\")\n",
    "cat(\"   - Median antibody level (protected):\", \n",
    "    round(median(cop_data$antibody_level[cop_data$infected == 0]), 2), \"\\n\")\n",
    "cat(\"   - ROC AUC:\", round(auc_value, 3), \"\\n\")\n",
    "cat(\"   - Optimal threshold (Youden's J):\", round(optimal_threshold, 2), \"\\n\")\n",
    "\n",
    "# Regression results\n",
    "cat(\"\\n3. REGRESSION ANALYSIS:\\n\")\n",
    "antibody_or <- exp(coef(model_multivariate)[\"log_antibody\"])\n",
    "cat(\"   - Odds ratio per log-unit antibody:\", round(antibody_or, 3), \"\\n\")\n",
    "cat(\"   - Interpretation: Each log-unit increase in antibody\\n\")\n",
    "cat(\"     reduces infection odds by\", round((1 - antibody_or) * 100, 1), \"%\\n\")\n",
    "\n",
    "# Protection thresholds\n",
    "cat(\"\\n4. PROTECTION THRESHOLDS:\\n\")\n",
    "for(i in 1:length(protection_levels)) {\n",
    "  cat(\"   -\", protection_levels[i] * 100, \"% protection:\", \n",
    "      round(antibody_thresholds[i], 2), \"\\n\")\n",
    "}\n",
    "\n",
    "# Statistical significance\n",
    "p_value <- summary(model_multivariate)$coefficients[\"log_antibody\", \"Pr(>|z|)\"]\n",
    "cat(\"\\n5. STATISTICAL SIGNIFICANCE:\\n\")\n",
    "cat(\"   - P-value for antibody association:\", \n",
    "    ifelse(p_value < 0.001, \"<0.001\", round(p_value, 3)), \"\\n\")\n",
    "cat(\"   - Conclusion:\", \n",
    "    ifelse(p_value < 0.05, \"Significant correlate of protection\", \"Not significant\"), \"\\n\")\n",
    "\n",
    "cat(\"\\n\" , \"=\"*60, \"\\n\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c6310d07",
   "metadata": {},
   "source": [
    "### 7.2 Clinical Interpretation\n",
    "\n",
    "Based on our analysis, we can draw several important conclusions:\n",
    "\n",
    "#### 7.2.1 Evidence for Correlate of Protection\n",
    "\n",
    "1. **Statistical Association**: The antibody level shows a strong statistical association with protection (p < 0.001)\n",
    "2. **Dose-Response Relationship**: Clear dose-response relationship observed between antibody levels and protection\n",
    "3. **Discriminatory Ability**: ROC AUC indicates good discriminatory ability of antibody levels\n",
    "\n",
    "#### 7.2.2 Threshold Interpretation\n",
    "\n",
    "- **50% Protection**: Represents the minimum level for population-level benefit\n",
    "- **80% Protection**: Clinically meaningful threshold for individual protection\n",
    "- **90% Protection**: High-confidence threshold for vulnerable populations\n",
    "\n",
    "#### 7.2.3 Clinical Implications\n",
    "\n",
    "1. **Vaccine Development**: These thresholds can guide vaccine development targets\n",
    "2. **Booster Strategies**: Can inform timing of booster doses\n",
    "3. **Population Immunity**: Helps assess population-level protection\n",
    "4. **Regulatory Decisions**: Provides evidence for vaccine approval\n",
    "\n",
    "#### 7.2.4 Study Limitations\n",
    "\n",
    "1. **Observational Design**: Cannot establish causation\n",
    "2. **Single Biomarker**: Only evaluated antibody levels\n",
    "3. **Follow-up Duration**: Limited to 12 months\n",
    "4. **Population Specific**: Results may not generalize to all populations"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "64af1fbe",
   "metadata": {},
   "source": [
    "## 8. Best Practices and Recommendations\n",
    "\n",
    "### 8.1 Statistical Best Practices for CoP Studies\n",
    "\n",
    "#### 8.1.1 Study Design Considerations\n",
    "\n",
    "1. **Sample Size Planning**:\n",
    "   - Power calculations should account for expected attack rates\n",
    "   - Consider stratification by important covariates\n",
    "   - Plan for loss to follow-up and missing data\n",
    "\n",
    "2. **Endpoint Selection**:\n",
    "   - Primary endpoint should be clinically meaningful\n",
    "   - Consider multiple endpoints (infection, disease, severity)\n",
    "   - Pre-specify endpoints to avoid bias\n",
    "\n",
    "3. **Biomarker Selection**:\n",
    "   - Include multiple immunological markers\n",
    "   - Consider functional assays (neutralization)\n",
    "   - Account for assay variability\n",
    "\n",
    "#### 8.1.2 Analysis Methodology\n",
    "\n",
    "1. **Model Selection**:\n",
    "   - Use appropriate statistical models for outcome type\n",
    "   - Consider non-linear relationships\n",
    "   - Account for confounding variables\n",
    "\n",
    "2. **Threshold Determination**:\n",
    "   - Use multiple approaches (ROC, quantile regression)\n",
    "   - Provide confidence intervals\n",
    "   - Consider clinical meaningfulness\n",
    "\n",
    "3. **Validation**:\n",
    "   - Cross-validation within study\n",
    "   - External validation when possible\n",
    "   - Bootstrap for uncertainty quantification\n",
    "\n",
    "#### 8.1.3 Reporting Guidelines\n",
    "\n",
    "1. **Transparency**:\n",
    "   - Report all analyses performed\n",
    "   - Provide code and data when possible\n",
    "   - Document assumptions and limitations\n",
    "\n",
    "2. **Completeness**:\n",
    "   - Include confidence intervals\n",
    "   - Report effect sizes, not just p-values\n",
    "   - Describe clinical significance\n",
    "\n",
    "### 8.2 Regulatory Considerations\n",
    "\n",
    "#### 8.2.1 Prentice Criteria\n",
    "\n",
    "For a biomarker to be considered a valid correlate of protection, it should satisfy:\n",
    "\n",
    "1. **Criterion 1**: Treatment (vaccination) significantly affects the biomarker\n",
    "2. **Criterion 2**: Treatment significantly affects the clinical outcome\n",
    "3. **Criterion 3**: Biomarker significantly predicts clinical outcome\n",
    "4. **Criterion 4**: Treatment effect on outcome is fully explained by biomarker\n",
    "\n",
    "#### 8.2.2 Regulatory Acceptance\n",
    "\n",
    "- **FDA Guidance**: Follow FDA guidance on biomarker qualification\n",
    "- **EMA Guidelines**: Consider EMA requirements for correlates\n",
    "- **WHO Recommendations**: Align with WHO guidelines for vaccine evaluation\n",
    "\n",
    "### 8.3 Future Directions\n",
    "\n",
    "#### 8.3.1 Methodological Advances\n",
    "\n",
    "1. **Machine Learning**: Explore ML approaches for threshold determination\n",
    "2. **Multi-marker Models**: Combine multiple biomarkers\n",
    "3. **Longitudinal Modeling**: Account for temporal changes\n",
    "4. **Causal Inference**: Methods to establish causation\n",
    "\n",
    "#### 8.3.2 Study Enhancements\n",
    "\n",
    "1. **Longer Follow-up**: Assess durability of protection\n",
    "2. **Diverse Populations**: Include various demographic groups\n",
    "3. **Variant Tracking**: Monitor against emerging variants\n",
    "4. **Mechanistic Studies**: Understand biological mechanisms\n",
    "\n",
    "### 8.4 R Code Best Practices\n",
    "\n",
    "#### 8.4.1 Code Organization\n",
    "\n",
    "```r\n",
    "# 1. Load libraries at the beginning\n",
    "# 2. Set seed for reproducibility\n",
    "# 3. Define functions before use\n",
    "# 4. Use meaningful variable names\n",
    "# 5. Comment your code extensively\n",
    "# 6. Save intermediate results\n",
    "# 7. Create publication-ready figures\n",
    "```\n",
    "\n",
    "#### 8.4.2 Documentation\n",
    "\n",
    "- Document all analysis steps\n",
    "- Include session information\n",
    "- Version control your code\n",
    "- Create reproducible reports\n",
    "\n",
    "#### 8.4.3 Quality Assurance\n",
    "\n",
    "- Validate results with independent analysis\n",
    "- Check for coding errors\n",
    "- Peer review statistical code\n",
    "- Test with simulated data\n",
    "\n",
    "---\n",
    "\n",
    "## Conclusion\n",
    "\n",
    "This statistical analysis plan provides a comprehensive framework for analyzing correlates of protection studies. The simulated analysis demonstrates key methodological approaches and provides R code for implementation. The identified correlates and thresholds can inform vaccine development, regulatory decisions, and public health strategies.\n",
    "\n",
    "**Key Takeaways:**\n",
    "1. Antibody levels show strong association with protection\n",
    "2. Multiple analytical approaches strengthen conclusions\n",
    "3. Confidence intervals provide important uncertainty quantification\n",
    "4. Clinical interpretation requires domain expertise\n",
    "5. Regulatory guidelines should inform study design and analysis\n",
    "\n",
    "This framework can be adapted for specific pathogens, populations, and study designs while maintaining rigorous statistical standards."
   ]
  }
 ],
 "metadata": {
  "language_info": {
   "name": "python"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
